These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22217873)

  • 1. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
    Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
    Abo-Ghalia MH; Soliman AE
    Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum.
    Zheng Y; Dong L; Hu C; Zhao B; Yang C; Xia C; Sun D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4223-6. PubMed ID: 25127102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Gasser RB; Keiser J; Gasser G
    Chemistry; 2013 Feb; 19(7):2232-5. PubMed ID: 23296750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel.
    Cao H; Liu H; Dömling A
    Chemistry; 2010 Nov; 16(41):12296-8. PubMed ID: 20845417
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
    Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
    Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Keiser J; Gasser G
    J Med Chem; 2012 Oct; 55(20):8790-8. PubMed ID: 23005702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
    Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2002; 59(4):313-20. PubMed ID: 12403307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and study of the antischistosomal potency and induced biological parameters of a new 2-palmitoyl analogue of the universal antihelminthic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2000; 57(1):53-9. PubMed ID: 10846798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel derivatives with antischistosomal activity: aromatic ring modification.
    Wang ZX; Chen JL; Qiao C
    Chem Biol Drug Des; 2013 Aug; 82(2):216-25. PubMed ID: 23617439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCR synthesis of praziquantel derivatives.
    Liu H; William S; Herdtweck E; Botros S; Dömling A
    Chem Biol Drug Des; 2012 Apr; 79(4):470-7. PubMed ID: 22151001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
    Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
    Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
    Barakat R; Elmorshedy H; Fenwick A
    Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.
    Xiao SH; Keiser J; Chollet J; Utzinger J; Dong Y; Endriss Y; Vennerstrom JL; Tanner M
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1440-5. PubMed ID: 17283188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni, and Schistosoma intercalatum.
    Gentilini M; Duflo B; Richard-Lenoble D; Brücker G; Danis M; Niel G; Meunier Y
    Acta Trop; 1980 Sep; 37(3):271-4. PubMed ID: 6106367
    [No Abstract]   [Full Text] [Related]  

  • 20. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
    Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
    Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.